These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 26799060)

  • 1. Idle thoughts of a 'well-calibrated' Bayesian in clinical drug development.
    Grieve AP
    Pharm Stat; 2016; 15(2):96-108. PubMed ID: 26799060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Creative and innovative statistics in clinical research and development.
    Maurer W
    Methods Inf Med; 2005; 44(4):551-60. PubMed ID: 16342922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bayesian statistics in medical devices: innovation sparked by the FDA.
    Campbell G
    J Biopharm Stat; 2011 Sep; 21(5):871-87. PubMed ID: 21830920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bayesian approaches in medical device clinical trials: a discussion with examples in the regulatory setting.
    Bonangelino P; Irony T; Liang S; Li X; Mukhi V; Ruan S; Xu Y; Yang X; Wang C
    J Biopharm Stat; 2011 Sep; 21(5):938-53. PubMed ID: 21830924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experience with reviewing Bayesian medical device trials.
    Pennello G; Thompson L
    J Biopharm Stat; 2008; 18(1):81-115. PubMed ID: 18161543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fisher, Neyman, and Bayes at FDA.
    Rubin DB
    J Biopharm Stat; 2016; 26(6):1020-1024. PubMed ID: 27611988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sample size estimation in single-arm clinical trials with multiple testing under frequentist and Bayesian approaches.
    Zaslavsky BG; Scott J
    J Biopharm Stat; 2012; 22(4):819-35. PubMed ID: 22651117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiplicity-calibrated Bayesian hypothesis tests.
    Guo M; Heitjan DF
    Biostatistics; 2010 Jul; 11(3):473-83. PubMed ID: 20212321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A flexible Bayesian approach for modeling monotonic dose-response relationships in drug development trials.
    Ohlssen D; Racine A
    J Biopharm Stat; 2015; 25(1):137-56. PubMed ID: 24836192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statistical approaches for conducting network meta-analysis in drug development.
    Jones B; Roger J; Lane PW; Lawton A; Fletcher C; Cappelleri JC; Tate H; Moneuse P;
    Pharm Stat; 2011; 10(6):523-31. PubMed ID: 22213533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The complexity of integrating speed and safety in drug development and approval.
    Charo RA
    JAMA Intern Med; 2013 Jul; 173(13):1165-6. PubMed ID: 23568604
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of the simulation in the clinical investigation].
    Monleón-Getino T
    Med Clin (Barc); 2013 Dec; 141(12):550-5. PubMed ID: 24238627
    [No Abstract]   [Full Text] [Related]  

  • 13. A practical guide to Bayesian group sequential designs.
    Gsponer T; Gerber F; Bornkamp B; Ohlssen D; Vandemeulebroecke M; Schmidli H
    Pharm Stat; 2014; 13(1):71-80. PubMed ID: 24038922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment and statistical modeling of the relationship between remotely sensed aerosol optical depth and PM2.5 in the eastern United States.
    Paciorek CJ; Liu Y;
    Res Rep Health Eff Inst; 2012 May; (167):5-83; discussion 85-91. PubMed ID: 22838153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bayesian hierarchical modeling for detecting safety signals in clinical trials.
    Xia HA; Ma H; Carlin BP
    J Biopharm Stat; 2011 Sep; 21(5):1006-29. PubMed ID: 21830928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bayesian approach to average bioequivalence using Bayes' factor.
    Ghosh P; Khattree R
    J Biopharm Stat; 2003 Nov; 13(4):719-34. PubMed ID: 14584718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Bayesian approach to the statistical analysis of device preference studies.
    Fu H; Qu Y; Zhu B; Huster W
    Pharm Stat; 2012; 11(2):149-56. PubMed ID: 22374584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statistical innovations in the medical device world sparked by the FDA.
    Campbell G; Yue LQ
    J Biopharm Stat; 2016; 26(1):3-16. PubMed ID: 26372890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bayesian approach to noninferiority trials for proportions.
    Gamalo MA; Wu R; Tiwari RC
    J Biopharm Stat; 2011 Sep; 21(5):902-19. PubMed ID: 21830922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bayesian correction for covariate measurement error: A frequentist evaluation and comparison with regression calibration.
    Bartlett JW; Keogh RH
    Stat Methods Med Res; 2018 Jun; 27(6):1695-1708. PubMed ID: 27647812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.